Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Methylprednisolone therapy for retinal laser injury
Yoram Solberg
, Galina Dubinski
, Marina Tchirkov
,
Michael Belkin
,
Mordechai Rosner
*
*
Corresponding author for this work
Sheba Medical Center at Tel Hashomer
Research output
:
Contribution to journal
›
Article
›
peer-review
30
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Methylprednisolone therapy for retinal laser injury'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Argon Laser
33%
Corticosteroids
33%
High-dose Methylprednisolone
66%
Histopathologic
33%
Intraperitoneal Injection
33%
Laser Damage
33%
Laser Exposure
33%
Laser Injury
100%
Laser Lesion
33%
Laser Photocoagulation
33%
Laser-induced
33%
Laser-induced Retinal Injury
66%
Methylprednisolone
33%
Methylprednisolone Therapy
100%
Methylprednisolone Treatment
66%
Neuroprotection
33%
Neuroprotective Agents
33%
Neuroprotective Effect
33%
Neuroprotective Therapy
33%
Perifovea
33%
Photocoagulation
66%
Photocoagulation Treatment
33%
Posterior Pole
33%
Rat Model
33%
Retina
66%
Retinal Laser
100%
Retinal Lesions
33%
Visual Impairment
33%
Pharmacology, Toxicology and Pharmaceutical Science
Corticosteroid
20%
Intraperitoneal Injection
20%
Methylprednisolone
100%
Neuroprotection
20%
Neuroprotective Agent
60%
Rat
20%
Rat Model
20%
Retina Injury
40%
Table Salt
20%
Visual Impairment
20%
Neuroscience
Corticosteroid
20%
Intraperitoneal Injection
20%
Methylprednisolone
100%
Neuroprotection
20%
Neuroprotective Agent
60%